{name}
{subtitle}
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~7 mi. (Magdeburg, Germany, +159 more cities)
facility
Universitaetsklinikum Magdeburg A.o.R. ( Site 0516)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~7 mi. (Magdeburg, Germany, +163 more cities)
facility
Universitaetsklinikum Magdeburg A.o.R. ( Site 0535)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
city
~20 mi. (Eimersleben, Germany, +107 more cities)
facility
Urologische Arztpraxis in Eisleben - Dr. med. Ralf Eckert
drug
abemaciclib, +2 more drugs
drug type
hormone therapy, +1 more type
A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
city
~49 mi. (Dessau, Germany, +144 more cities)
facility
GSK Investigational Site
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~64 mi. (Halle (Saale), Germany, +140 more cities)
facility
Universitaetsklinikum Halle ( Site 0213)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~64 mi. (Halle (Saale), Germany, +142 more cities)
facility
Universitaetsklinik und Polikl
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
city
~64 mi. (Halle (Saale), Germany, +16 more cities)
facility
Site DE49001
drug
cytarabine, +3 more drugs
drug type
chemotherapy, +2 more types